News Briefing channel feed – Endpoints News

News Briefing channel feed

Lexeo brings in $95M; FDA lifts hold on Nurix cancer trial

Last year

Inventiva restarts PhIII screening for MASH trial; CDMO announces small public offering

Last year

Ultimovacs' melanoma vaccine fails in PhII; Regenxbio’s $140M offering

Last year

Apogee's $350M offering; BiomX merges with Adaptive Phage

Last year

BridgeBio's $250M offering; ViiV's PhI data for ultra-long-acting HIV treatment

Last year

FDA pushes back decision on Zevra’s drug; Revance to raise $100M

Last year

Achieve Life Sciences nabs $124M; Pierre Fabre buys pan-RAF program from Kinnate

Last year

Avidity to raise $400M; Sato pays Arcutis $25M upfront to license topical roflumilast in Japan

Last year

Viking's $350M offering; Baker Brothers leads another PIPE

Last year

Denali’s $500M placement; Brain health startup raises $26M

Last year

Milestone’s plans to resubmit heart drug; Alvotech’s $166M offer; Vaccine biotech raises $11M

Last year

Karuna pushes back KarXT data readouts; Vir, GSK end flu collaboration; Silence’s $10M milestone payment

Last year

MD Anderson buys tech from Bellicum; Tarsus’ Lyme disease trial data; Rigel takes Gavreto

Last year

New dose schedule for J&J bispecific; Layoffs at Ring Therapeutics; Regeneron’s priority review

Last year

Iovance's $211M offering; Almirall licenses Novo drug; AstraZeneca files Dato-DXd; Sonata layoffs

Last year

XOMA to buy Kinnate; A pain biotech’s small IPO

Last year

KalVista wants to raise $160M; Prime Medicine's upsized offering; Applied Tx's PhIII data

Last year

Merrimack to dissolve after recording $225M milestone; Cogent's $225M placement

Last year

BMS, VantAI team up; CRISPR Therapeutics to raise $280M; Ono Pharma's deal with Shattuck Labs

Last year

Immunovant's plans for autoimmune asset; Wall Street worries about Moderna’s RSV candidate

Last year

Vicore sells rights to IPF drug in Japan; Roche to lay off 340 workers; Sensorion’s €50M offering

Last year

Lilly picks a Foghorn target; Mineralys’ $120M PIPE; Sana's $165M offering

Last year

Jazz's KRAS deal with Redx; Alto Neuroscience upsizes IPO

Last year

Immunome buys desmoid tumor asset; UK looks into Thermo Fisher-Olink deal; Kyverna's upsized IPO

Last year

First page Previous page 9 10 111213 14 15 Next page Last page